AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Clever Leaves Holdings Inc. operates as a cannabis company.
The company operates through two segments, Cannabinoid and Non-Cannabinoid.
The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally.
The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States.
The company was founded in 2017 and is based in Boca Raton, Florida.
Country | United States |
IPO Date | Dec 18, 2020 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 296 |
CEO | Andres Fajardo |
Contact Details
Address: 6501 Congress Avenue Boca Raton, Florida United States | |
Website | https://www.cleverleaves.com |
Stock Details
Ticker Symbol | CLVR |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001819615 |
CUSIP Number | 186760104 |
ISIN Number | CA1867602031 |
Employer ID | 00-0000000 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Andres Fajardo | Co-Founder, Chief Executive Officer & Director |
Gustavo Escobar | Chief Operating Officer |
Henry R. Hague III | Chief Financial Officer |
Andrew Miller | Head of Business Development |
Camilo Bohorquez | Head of Colombia |
Caroline Kliess | Managing Director of Germany |
Jackie Keshner | Investor Relations Executive |
Julian Wilches | Chief Regulatory Officer |
Marta Pinto Leite | General Counsel & Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 21, 2024 | 3 | Filing |
May 21, 2024 | SC 13D/A | [Amend] Filing |
May 16, 2024 | 15-12G | Filing |
May 15, 2024 | SC 13D | Filing |
May 06, 2024 | S-8 POS | Filing |
May 06, 2024 | S-8 POS | Filing |
May 06, 2024 | S-8 POS | Filing |
May 06, 2024 | POS AM | Filing |
May 06, 2024 | 25 | Filing |
Apr 26, 2024 | 8-K | Current Report |